If you miss your regular dosing schedule, take the missed dose as soon as you remember
The mazdutide versus retatrutide comparison highlights how different dual and triple agonist approaches are all converging on the same goal of maximizing weight loss while preserving metabolic health
Low Blood Sugar Semaglutide is a glucagon-like peptide-1 receptor agonist, and although its insulinotropic effect is glucose-dependent, it can still lower glucose in people without diabetes, particularly when combined with other glucose-lowering therapies or prolonged fasting
Increased physical activity and delayed onset muscle soreness Weight loss creates energy
First-time prescribing rates of AOM semaglutide increased in early 2024 and then have remained relatively stable and flat
There shouldn't be judgment in people's decisions for healthcare. However, experts recommend only taking weight loss medications if you meet the criteria for their use